Shr-A1811
HER2-Postive Breast Cancer
Tianjin Medical University Cancer Institute and HospitalPhase 2
—
Rating in progress
Shr-A1811 in HER2-Postive Breast Cancer is in the Floatz rating universe. The engine has not yet published a v0.2 rating for this asset. This page will update automatically once scoring completes.
Methodology v0.2 · Active